PTP1B Inhibitor

CAS: 765317-72-4

Ref. 3D-QFB31772

Produktinformation

• Name: PTP1B Inhibitor
• Synonyme: 6-Benzofuransulfonamide, 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]-

Beschreibung

PTP1B Inhibitor is a drug that is used to treat type 2 diabetes. It inhibits the activation of PTP1B, a protein that regulates the uptake of glucose from the blood. This inhibition decreases insulin-stimulated glucose uptake and increases sodium-dependent glucose uptake in peripheral tissues. PTP1B Inhibitor is also known as an antidiabetic agent due to its ability to regulate insulin secretion and blood sugar levels. The hydrogen bonds between this drug and human protein are very stable, which makes it more difficult for enzymes to break down the complex. PTP1B Inhibitor has been shown to have an effect on fatty acid metabolism and signal pathways, leading to potential metabolic disorders such as obesity or type 2 diabetes.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 741.45 g/mol
• Formel: C₂₆H₁₉Br₂N₃O₇S₃
• Reinheit: Min. 95 Area-%
• Farbe/Form: Powder